A nurse is reinforcing teaching with a client who is to begin taking lansoprazole.
Which of the following statements by the client indicates an understanding of the teaching?

Choice A rationale

Testicular cancer screening is recommended for younger males, typically from adolescence to their mid-thirties, as this cancer is most prevalent in this demographic. Routine self-examinations can aid early detection of painless lumps or changes in testicle size, leading to prompt diagnosis and treatment.

Choice B rationale

Colorectal cancer screening is generally recommended starting at age 45 or earlier if there are risk factors such as a family history. This examination is not a priority for the average 18-year-old without specific indications, as colorectal cancer incidence is low in this age group.

Choice C rationale

Prostate cancer screening is not indicated for an 18-year-old, as it typically affects older males, with recommendations for screening starting around age 50. Younger individuals without genetic predispositions or symptoms do not require this screening, as the risk is negligible at this stage of life.

Choice D rationale

Skin cancer screening is important but not specific to the age of 18, as it applies to individuals of all ages, particularly those with risk factors like excessive sun exposure or familial melanoma history. While relevant, this is not the most age-appropriate cancer screening for the client compared to testicular cancer.

Choice A rationale

Cervical cancer screenings are recommended to begin at age 21, regardless of sexual history. Delaying until age 40 overlooks guidelines that target the detection of precancerous changes earlier in life, maximizing prevention efforts.

Choice B rationale

The combination of Pap and HPV tests every five years from ages 30 to 65 aligns with current recommendations. HPV is a critical etiological agent, and co-testing enhances sensitivity for detecting high-risk oncogenic strains or cellular abnormalities.

Choice C rationale

Immunization against HPV significantly reduces cervical cancer risk but does not eliminate it. Screening remains critical due to the vaccine's limited coverage of HPV types and possible pre-immunization exposure.

Choice D rationale

Lifetime screenings are not necessary unless there are risk factors like HIV or previous abnormal results. Guidelines recommend stopping screening after age 65 for women with adequate prior negative results.